INCYTE Pharmaceuticals, Inc. focuses on biopharmaceutical research and development, targeting unmet medical needs. The company is dedicated to advancing innovation and improving patient outcomes. It collaborates with partners to bring new therapies to market.

Contact:
3174 Porter Dr.
Palo Alto, California 94304
United States

Phone: 650-855-555
Fax: 650-855-572

Team:
Paul A. Friedman, Partner

Website:
http://www.incyte.com

Company Type:
Venture Capital Firm

Investment Industries:
Biotechnology, Business and consumer products, Computer hardware, Financial services, Healthcare, Industrial and energy products, IT services, Media and entertainment, Medical equipment, Networking, Real estate, Retailing and distribution, Semiconductors, Software, Telecommunications

Investment Stages:
1st round, 2nd round, 3rd round, 4th round and later, Buyout and acquisition, Mezzanine, Pre-IPO, Seed